Yuki Matsuda

2.2k total citations
77 papers, 1.2k citations indexed

About

Yuki Matsuda is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, Yuki Matsuda has authored 77 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Psychiatry and Mental health, 20 papers in Pharmacology and 14 papers in Neurology. Recurrent topics in Yuki Matsuda's work include Schizophrenia research and treatment (26 papers), Bipolar Disorder and Treatment (21 papers) and Treatment of Major Depression (20 papers). Yuki Matsuda is often cited by papers focused on Schizophrenia research and treatment (26 papers), Bipolar Disorder and Treatment (21 papers) and Treatment of Major Depression (20 papers). Yuki Matsuda collaborates with scholars based in Japan, United States and Finland. Yuki Matsuda's co-authors include Taro Kishi, Nakao Iwata, Kenji Sakuma, Toshikazu Ikuta, Makoto Okuya, Masakazu Hatano, Kazuo Mishima, Ikuo Nomura, Shinji Matsunaga and Kazuto Oya and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Psychological Medicine.

In The Last Decade

Yuki Matsuda

73 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Matsuda Japan 19 587 242 157 152 141 77 1.2k
Dong-Bin Cai China 21 443 0.8× 228 0.9× 137 0.9× 308 2.0× 95 0.7× 43 988
J.-P. Olié France 16 423 0.7× 218 0.9× 214 1.4× 134 0.9× 151 1.1× 37 1.1k
Jun Ishigooka Japan 24 757 1.3× 291 1.2× 223 1.4× 164 1.1× 196 1.4× 123 1.6k
Lea T. Drye United States 24 940 1.6× 415 1.7× 206 1.3× 149 1.0× 106 0.8× 46 1.9k
Jingping Zhao China 18 749 1.3× 195 0.8× 239 1.5× 167 1.1× 112 0.8× 65 1.7k
Alfredo Carlo Altamura Italy 22 771 1.3× 266 1.1× 232 1.5× 122 0.8× 162 1.1× 66 1.6k
Sheng‐Min Wang South Korea 23 580 1.0× 494 2.0× 229 1.5× 312 2.1× 161 1.1× 113 1.7k
Philipp Rothe Germany 10 1.1k 1.8× 242 1.0× 105 0.7× 175 1.2× 119 0.8× 17 1.4k
Martina Curto Italy 24 895 1.5× 86 0.4× 134 0.9× 198 1.3× 103 0.7× 52 1.4k
Sylvain Grignon Canada 18 454 0.8× 189 0.8× 176 1.1× 167 1.1× 154 1.1× 45 989

Countries citing papers authored by Yuki Matsuda

Since Specialization
Citations

This map shows the geographic impact of Yuki Matsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Matsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Matsuda more than expected).

Fields of papers citing papers by Yuki Matsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Matsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Matsuda. The network helps show where Yuki Matsuda may publish in the future.

Co-authorship network of co-authors of Yuki Matsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Matsuda. A scholar is included among the top collaborators of Yuki Matsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Matsuda. Yuki Matsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kishi, Taro, Toshikazu Ikuta, Kenji Sakuma, et al.. (2024). Theta burst stimulation for depression: a systematic review and network and pairwise meta-analysis. Molecular Psychiatry. 29(12). 3893–3899. 11 indexed citations
2.
Kishi, Taro, Kenji Sakuma, Yuki Matsuda, Shinsuke Kito, & Nakao Iwata. (2023). Intermittent theta burst stimulation vs. high-frequency repetitive transcranial magnetic stimulation for major depressive disorder: A systematic review and meta-analysis. Psychiatry Research. 328. 115452–115452. 18 indexed citations
4.
Kishi, Taro, et al.. (2023). Repetitive transcranial magnetic stimulation for mania: A systematic review and meta‐analysis. Bipolar Disorders. 25(2). 160–161. 2 indexed citations
5.
Kishi, Taro, Toshikazu Ikuta, Kenji Sakuma, et al.. (2023). Safety profile of antidepressant for Japanese adults with major depressive disorder: A systematic review and network meta‐analysis. Psychiatry and Clinical Neurosciences. 78(2). 142–144. 1 indexed citations
6.
Kishi, Taro, Kenji Sakuma, Masakazu Hatano, et al.. (2023). Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta‐analysis. Neuropsychopharmacology Reports. 44(1). 216–220. 1 indexed citations
7.
Kishi, Taro, Toshikazu Ikuta, Kenji Sakuma, et al.. (2022). Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Molecular Psychiatry. 28(1). 402–409. 71 indexed citations
8.
Kishi, Taro, Kenji Sakuma, Masakazu Hatano, et al.. (2022). Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression. Molecular Psychiatry. 28(3). 974–976. 10 indexed citations
11.
Yamazaki, Ryuichi, Hiroyuki Ohbe, Yuki Matsuda, et al.. (2021). Early Electroconvulsive Therapy in Patients With Major Depressive Disorder. Journal of Ect. 37(3). 176–181. 3 indexed citations
12.
Kishi, Taro, Yuki Matsuda, Kenji Sakuma, et al.. (2021). Recurrence Rates in Stable Bipolar Disorder Patients after Drug Discontinuation versus Drug Maintenance: A Systematic Review and Meta-analysis – Corrigendum. Psychological Medicine. 51(15). 2730–2730. 1 indexed citations
13.
Matsuda, Yuki, Yujiro Furukawa, Ryuichi Yamazaki, et al.. (2020). Mirtazapine‐induced long QT syndrome in an elderly patient: a case report. Psychogeriatrics. 20(4). 536–537. 3 indexed citations
14.
Kishi, Taro, Toshikazu Ikuta, Yuki Matsuda, Kenji Sakuma, & Nakao Iwata. (2020). Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis. Psychopharmacology. 237(5). 1459–1470. 17 indexed citations
15.
Matsuda, Yuki, Shinsuke Kito, Yoshio Igarashi, & Masahiro Shigeta. (2020). Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial. Neuropsychobiology. 79(3). 208–213. 11 indexed citations
16.
Kishi, Taro, Toshikazu Ikuta, Shinji Matsunaga, et al.. (2017). Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population. Neuropsychiatric Disease and Treatment. Volume 13. 1281–1302. 17 indexed citations
17.
Kishi, Taro, Yuki Matsuda, Shinji Matsunaga, et al.. (2017). Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial. Neuropsychiatric Disease and Treatment. Volume 13. 117–125. 3 indexed citations
18.
Kishi, Taro, Yuki Matsuda, Shinji Matsunaga, et al.. (2015). A cross-sectional survey to investigate the prevalence of pain in Japanese patients with major depressive disorder and schizophrenia. Comprehensive Psychiatry. 59. 91–97. 14 indexed citations
19.
Murakami, Takaaki, et al.. (2014). Pseudohypoparathyroidism Type II in a Woman with a History of Thyroid Surgery. Internal Medicine. 53(7). 743–747. 2 indexed citations
20.
Kishi, Taro, Yuki Matsuda, Hiroshi Nakamura, & Nakao Iwata. (2012). Blonanserin for schizophrenia: Systematic review and meta-analysis of double-blind, randomized, controlled trials. Journal of Psychiatric Research. 47(2). 149–154. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026